Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Concentrix (CNXC) EBT (2020 - 2025)

Historic EBT for Concentrix (CNXC) over the last 6 years, with Q4 2025 value amounting to -$1.4 billion.

  • Concentrix's EBT fell 138086.99% to -$1.4 billion in Q4 2025 from the same period last year, while for Nov 2025 it was -$1.2 billion, marking a year-over-year decrease of 49503.0%. This contributed to the annual value of -$1.2 billion for FY2025, which is 49503.0% down from last year.
  • Concentrix's EBT amounted to -$1.4 billion in Q4 2025, which was down 138086.99% from $111.4 million recorded in Q3 2025.
  • Concentrix's EBT's 5-year high stood at $162.6 million during Q4 2022, with a 5-year trough of -$1.4 billion in Q4 2025.
  • Moreover, its 5-year median value for EBT was $112.2 million (2024), whereas its average is $34.3 million.
  • In the last 5 years, Concentrix's EBT soared by 91704.22% in 2021 and then tumbled by 138086.99% in 2025.
  • Concentrix's EBT (Quarter) stood at $154.9 million in 2021, then increased by 4.94% to $162.6 million in 2022, then crashed by 52.57% to $77.1 million in 2023, then surged by 46.42% to $112.9 million in 2024, then tumbled by 1380.87% to -$1.4 billion in 2025.
  • Its EBT was -$1.4 billion in Q4 2025, compared to $111.4 million in Q3 2025 and $51.7 million in Q2 2025.